Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
SHC014748M
DRUG
2 trials
Sponsors
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Conditions
B-Cell Non-Hodgkin Lymphomas(NHL)
Chronic Lymphocytic Leukemia (CLL)
Follicular Lymphoma(FL)
Marginal Zone Lymphoma(MZL)
Small Lymphocytic Lymphoma (SLL)
Phase 1
Safety, Tolerability, and Pharmacokinetics of SHC014748M in Patients With Indolent B-Cell Hematologic Malignancies
NCT03588598
Nanjing Sanhome Pharmaceutical, Co., Ltd.
B-Cell Non-Hodgkin Lymphomas(NHL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Start: 2018-09-07
End: 2019-12-31
Target: 40
Updated: 2019-04-30
Phase 2
Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma
NCT04431089
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Follicular Lymphoma(FL), Marginal Zone Lymphoma(MZL)
Start: 2020-05-09
End: 2021-07-31
Target: 122
Updated: 2021-01-28
Related Papers
Preliminary Results from a Phase I Study of SHC014748M in Patients with Relapsed or Refractory Indolent B-Cell Lymphomas
Blood
2019-11-13
1 citations